DiscoverToday's discussion on unraveling BPC 157 PeptideBeyond GLP-1 & GIP: Unpacking the Power of Retatrutide's Triple Agonism
Beyond GLP-1 & GIP: Unpacking the Power of Retatrutide's Triple Agonism

Beyond GLP-1 & GIP: Unpacking the Power of Retatrutide's Triple Agonism

Update: 2025-06-04
Share

Description

"Step into the forefront of metabolic science with our deep dive into Retatrutide. This podcast explores the innovative 'triple agonist' peptide, examining its unique mechanism of action on GLP-1, GIP, and glucagon receptors. We'll unpack the groundbreaking clinical trial data, discuss its significant impact on weight loss and type 2 diabetes management, and explore the broader implications for metabolic health. Join us to understand why Retatrutide is being hailed as a potential game-changer in the fight against obesity and related conditions."

Comments 
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Beyond GLP-1 & GIP: Unpacking the Power of Retatrutide's Triple Agonism

Beyond GLP-1 & GIP: Unpacking the Power of Retatrutide's Triple Agonism